Fecal Serine Protease Profiling in Inflammatory Bowel Diseases

Amin Jablaoui(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Aïcha Kriaa(Université Paris-Saclay), Héla Mkaouar(Microbiologie de l’alimentation au service de la santé), Nizar Akermi(Université Paris-Saclay), Souha Soussou(Microbiologie de l’alimentation au service de la santé), Magdalena Wysocka(University of Gdańsk), Dominika Wołoszyn(University of Gdańsk), Ali Amouri(Hopital Universitaire Hedi Chaker), Ali Gargouri(University of Sfax), Emmanuelle Maguin(Université Paris-Saclay), Adam Lesner(University of Gdańsk), Moez Rhimi(Microbiologie de l’alimentation au service de la santé)
Frontiers in Cellular and Infection Microbiology
February 4, 2020
Cited by 94Open Access
Full Text

Abstract

Serine proteases are extensively known to play key roles in many physiological processes. However, their dysregulation is often associated to several diseases including inflammatory bowel diseases (IBD). Here, we used specific substrates to monitor fecal protease activities in a large cohort of healthy and IBD patients. Of interest, serine protease activity was 10-fold higher in IBD fecal samples compared to healthy controls. Moreover, functional analysis of these fecal proteolytic activities revealed that the most increased activities are trypsin-like, elastase-like and cathepsin G-like. We also show for the first time, an increase of proteinase 3-like activity in these samples compared to controls. Results presented here will guide further investigations to better understand the relevance of these peptidases in IBD.


Related Papers

No related papers found

Powered by citation graph analysis